Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUPPRESS: Prophylactic PVC Suppression to Prevent LV Dysfunction
NCT05784051Phase 4Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2023
- Primary completion
- Jun 2027
01
Overview
Phase 4, randomised, open-label trial in premature ventricular contraction (PVC) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Occurrence of Left Ventricular Dysfunction (PVC-iCMP) at 24 months. Planned start Oct 2023; status: not yet recruiting.
02
Conditions
premature ventricular contraction (PVC)
Beyond the preview
Go deeper on NCT05784051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05784051.